All Marketing Authorization Holders (MAHs) of medicines are hereby informed that the following categories of applications, which remain pending at the Pricing Division due to non-response from applicants within three months from the initial communication from the NMRA, will be considered for rejection from both the Pricing Review Process and the Registration Process at the NMRA:

·       Applications where applicants have not submitted there quested price details.

·       Applications where applicants have not responded to the MRP determinations officially communicated by the NMRA.

A notification letter will be issued to inform the withdrawal and closure of these applications and applicants can submit any concerns or clarifications regarding this decision within one month of this letter. Failure to respond within this period will result in the permanent rejection of your application by the NMRA.  

Please note that, after rejection,if the applicants wish to proceed further, these product registration applications must be resubmitted as a new application to the NMRA.

‍